REGENERON PHARMACEUTICALS, INC. Other Non-Current Assets
REGENERON PHARMACEUTICALS, INC. (REGN) had Other Non-Current Assets of $2.31 billion as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-07-30
- 2026-06-30: Other Assets, Noncurrent $2.31B.
- 2026-03-31: Other Assets, Noncurrent $2.13B.
- 2025-12-31: Other Assets, Noncurrent $1.82B.
- 2025-09-30: Other Assets, Noncurrent $1.67B.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $2.31B 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $2.13B 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $1.82B 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $1.67B 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $1.54B 10-Q · filed 2025-08-01 | |
| 2025-03-31 | $1.39B 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $1.14B 10-K · filed 2026-02-04 | |
| 2024-09-30 | $1.04B 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $993.80M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $470.20M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $444.10M 10-K · filed 2025-02-05 | |
| 2023-09-30 | $409.90M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $393.20M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $349.60M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $336.40M 10-K · filed 2024-02-05 | |
| 2022-09-30 | $320.20M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $269.90M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $262.00M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $216.10M 10-K · filed 2023-02-06 | $222.80M 10-K · filed 2022-02-07 |
| 2021-09-30 | $145.90M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $142.90M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $145.70M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $168.10M 10-K · filed 2022-02-07 | |
| 2020-09-30 | $168.80M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $175.50M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $161.20M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $144.70M 10-K · filed 2021-02-08 | |
| 2019-09-30 | $137.90M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $139.80M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $144.30M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $127.40M 10-K · filed 2020-02-07 | |
| 2018-09-30 | $125.20M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $85.67M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $78.98M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $77.90M 10-K · filed 2019-02-07 | $77.87M 10-K · filed 2018-02-08 |
| 2017-09-30 | $36.62M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $36.96M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $37.09M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $20.29M 10-K · filed 2018-02-08 | |
| 2016-09-30 | $20.70M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $6.71M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $5.79M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $5.81M 10-K · filed 2017-02-09 | |
| 2015-09-30 | $4.58M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $4.14M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $4.47M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $3.03M 10-K · filed 2016-02-11 | |
| 2014-09-30 | $3.42M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $8.88M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $5.34M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $5.33M 10-K · filed 2015-02-12 | |
| 2013-09-30 | $4.41M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $15.21M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $20.08M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $23.10M 10-K · filed 2014-02-13 | |
| 2012-09-30 | $18.32M 10-Q · filed 2012-10-24 | |
| 2012-06-30 | $19.57M 10-Q · filed 2012-07-25 | |
| 2012-03-31 | $20.39M 10-Q · filed 2012-04-26 | |
| 2011-12-31 | $6.24M 10-K · filed 2013-02-15 | $19.14M 10-K · filed 2012-02-21 |
| 2011-09-30 | $13.02M 10-Q · filed 2011-10-27 | |
| 2011-06-30 | $12.29M 10-Q · filed 2011-07-28 | |
| 2011-03-31 | $10.23M 10-Q · filed 2011-05-03 | |
| 2010-12-31 | $6.79M 10-K · filed 2012-02-21 | |
| 2010-09-30 | $6.86M 10-Q · filed 2010-10-28 | |
| 2010-06-30 | $6.70M 10-Q · filed 2010-07-28 | |
| 2009-12-31 | $7.34M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |